Researchers have discovered a significant and  previously unknown mechanism that many bacteria use to resist antibiotics.
        Using a combination of computation and  physical observation in the laboratory, the researchers have unraveled a  sophisticated process that some commonly occurring bacteria use to save  themselves from the rifamycin class of antibiotics, which occur naturally and  are also manufactured to treat infectious diseases.
        Rifamycins work by binding to RNA polymerase,  a protein essential for bacterial life.
        The resistant bacteria, which occur widely in  the environment and some human pathogens, have developed a protein that can  eject the antibiotic from RNA polymerase. Once the rifamycin is dislodged, they  use specially adapted proteins to attack and destroy it.
        "What we've discovered is a brand-new trick up  the sleeves of bacteria to evade this class of antibiotics," explains  researcher Gerry Wright, who leads the McMaster-based Global Nexus for  Pandemics and Biological Threats. "It's like a one-two punch. It's fascinating  and it's so crafty."
        The discovery shows that the mechanisms of  antimicrobial resistance (AMR) are more complex and highly evolved than  scientists had previously recognized.
     
    Now Wright and his colleagues are combing  their database of tens of thousands of samples to see if other bacteria use  parallel processes and whether they reveal vulnerabilities that can be  exploited to create urgently needed new antibiotics.
        Their work is described in a paper published  online in the influential journal Molecular Cell.
        Wright says the discovery gives him a new  respect for nature's adaptability and renews his enthusiasm for finding and  exposing other methods bacteria use to ensure their survival.
        AMR is a huge and growing global health  concern that should be commanding much more attention and far more research  resources, Wright says.
        Ref:
    Gerry Wright et. al, HelR is a helicase-like  protein that protects RNA polymerase from rifamycin antibiotics, Molecular Cell,  28-Jul-2022, DOI: 10.1016/j.molcel.2022.06.019 
     
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.